Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will evaluate the safety of the pessary device by objective evaluation of vaginal wall integrity and subjective assessment of comfort during in-use conditions.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| pad | Placebo Comparator | absorbent pad control |
|
| pessary | Experimental | disposable, single-use pessary |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| pessary | Device | disposable, single-use pessary |
| |
| Absorbent pad |
| Measure | Description | Time Frame |
|---|---|---|
| Treatment-emergent Serious Adverse Event | proportion of intent-to-treat subjects who experience a treatment-emergent serious adverse event | 3 month |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Randall Severance, MD | Radiant Research, Inc. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Study Center | Chandler | Arizona | 85224 | United States |
224 subjects signed an informed consent, 79 did not meet inclusion/exclusion criteria and were screen failed.
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Pad Control | absorbent pad control |
| FG001 | Pessary | pessary: disposable, single-use |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Intent-to-Treat (ITT)
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Pad Control | absorbent pad control Absorbent pad |
| BG001 | Pessary | disposable, single-use pessary pessary: disposable, single-use pessary |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Treatment-emergent Serious Adverse Event | proportion of intent-to-treat subjects who experience a treatment-emergent serious adverse event | Intent-to-treat (ITT) | Posted | Number | participants | 3 month |
|
|
3 months
All AEs as reported by the subject from Visit 1 (screening) through Visit 5 (exit) were recorded.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Pad Control | absorbent pad control |
Not provided
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Candida test positive | Investigations | MedDRA v 17.1 | Non-systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Mylissa Trowbridge | Procter & Gamble Company Global Clinical Sciences | trowbridge.mm@pg.com |
Not provided
| ID | Term |
|---|---|
| D014550 | Urinary Incontinence, Stress |
| ID | Term |
|---|---|
| D014549 | Urinary Incontinence |
| D014555 | Urination Disorders |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D010570 | Pessaries |
| D041342 | Absorbent Pads |
| ID | Term |
|---|---|
| D013523 | Surgical Equipment |
| D004864 | Equipment and Supplies |
| D004865 | Equipment and Supplies, Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Device |
|
|
| Withdrawal by Subject |
|
| Lost to Follow-up |
|
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Participants |
|
|
| 0 |
| 73 |
| 8 |
| 73 |
| EG001 | Pessary | disposable, single-use pessary | 0 | 72 | 7 | 72 |
| Upper Respiratory Tract Infection | Infections and infestations | MedDRA v 17.1 | Non-systematic Assessment |
|
| vaginal hemorrhage | Reproductive system and breast disorders | MedDRA v 17.1 | Non-systematic Assessment | this adverse event corresponds to vaginal spotting in 3 subjects, and vaginal bleeding in 1 subject |
|
The STUDY SITE and PRINCIPAL INVESTIGATOR agree that all data, calculations, interpretations, opinions and recommendations regarding the STUDY (hereinafter referred to as "RESULTS") shall be the property of P&G. The STUDY SITE and PRINCIPAL INVESTIGATOR agree to consider the RESULTS as INFORMATION subject to confidentiality restrictions
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D059411 | Lower Urinary Tract Symptoms |
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |